4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-054833
EVP, Research & CSO sold 5,560 shares at $43.03 ($239,236)
- EVP, Research & CSO acquired 5,560 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2020-10-13 | Option exercise | +5,560 | $1.53 | $8,507 | 29,260 | D |
| Virgin Herbert EVP, Research & CSO | 2020-10-13 | Sale | −5,560 | $43.03 | $239,236 | 23,700 | D |
| Derivatives | |||||||
| Virgin Herbert EVP, Research & CSO | 2020-10-13 | Option exercise · Stock Option (Right to Buy) | −5,560 | 454,315 | D | ||
| Open-market sales · 5,560 sh · avg $43.03 · $239,236 | |||||||
Loading xslF345X03/doc4.xml…